Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Peroxiredoxin 4 anticorps

Cet anticorps anti-Peroxiredoxin 4 est un anticorps Souris Monoclonal détectant Peroxiredoxin 4 dans ELISA et Coat. Adapté pour Humain.
N° du produit ABIN6939084

Aperçu rapide pour Peroxiredoxin 4 anticorps (ABIN6939084)

Antigène

Voir toutes Peroxiredoxin 4 (PRDX4) Anticorps
Peroxiredoxin 4 (PRDX4)

Reactivité

  • 62
  • 31
  • 18
  • 6
  • 4
  • 4
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Humain

Hôte

  • 48
  • 18
  • 1
  • 1
Souris

Clonalité

  • 47
  • 21
Monoclonal

Conjugué

  • 41
  • 7
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp Peroxiredoxin 4 est non-conjugé

Application

  • 45
  • 24
  • 22
  • 9
  • 8
  • 7
  • 6
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
ELISA, Coating (Coat)

Clone

CPTC-PRDX4-2
  • Specificité

    The peroxiredoxin (PRX) family comprises six antioxidant proteins, PRX I, II, III, IV, V and VI, which protect cells from reactive oxygen species (ROS) by preventing the metal-catalyzed oxidation of enzymes. The PRX proteins primarily utilize thioredoxin as the electron donor for antioxidation, although they are fairly promiscuous with regard to the hydroperoxide substrate. In addition to protection from ROS, peroxiredoxins are also involved in cell proliferation, differentiation and gene expression. PRX I, II, IV and VI show diffuse cytoplasmic localization, while PRX III and V exhibit distinct mitochondrial localization. The human PRX IV gene is expressed in many tissues. It exists as a precursor protein, which is only detected in testis, and aprocessed secreted form. PRX IV is highly expressed in lung cancer and is necessary for the promotion of lung cancer in vitro. Studies have demonstrated that PRX IV positive expression is significantly correlated with recurrences and shorter disease-free survival in patients with early-stage lung squamous cell carcinoma, and therefore can be used as a prognostic marker in lung squamous cell carcinoma.

    Réactivité croisée (Details)

    Human,

    Purification

    200ug/ml of Ab Purified from Bioreactor Concentrate by Protein A/G.

    Immunogène

    Recombinant full-length human PRDX4 protein

    Isotype

    IgG2b
  • Indications d'application

    Positive Control: HepG2, HeLa and Jurkat cell lysates. Ovarian carcinoma tissue.

    Known Application: ELISA (For coating, order Ab without BSA), Optimal dilution for a specific application should be determined.

    Restrictions

    For Research Use only
  • Concentration

    200 μg/mL

    Buffer

    Prepared in 10 mM PBS with 0.05 % BSA and 0.05 % azide.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C,-80 °C

    Stockage commentaire

    Antibody with azide - store at 2 to 8 °C. Antibody is stable for 24 months. Non-hazardous. Also available WITHOUT BSA & azide at 1.0mg/ml.

    Date de péremption

    24 months
  • Antigène

    Peroxiredoxin 4 (PRDX4)

    Autre désignation

    PRDX4

    Sujet

    Antioxidant enzyme AOE372, EC 1.11.1.15, Thioredoxin dependent peroxide reductase A0372, TRANK,Peroxiredoxin 4 (Prognostic Marker for Lung SqCC)
    Cellular localisation: Cytoplasm. Secreted.

    Poids moléculaire

    27kDa

    ID gène

    10549, 83383

    UniProt

    Q13162
Vous êtes ici:
Chat with us!